Randomized trial evaluated the immunomodulatory effects of probiotics on dendritic cell responses, indicating potential benefits for immune regulation.
This study explored the immunomodulatory properties of the probiotic strains Lacticaseibacillus rhamnosus LR-32 and Lactobacillus acidophilus LA-5 by evaluating their effects on human dendritic cell (DC) responses. Immature DCs were obtained from human CD14⁺ monocytes and challenged with E. coli LPS and/or probiotic lactobacilli at a DC ratio of 1:10. Relative transcription of inflammatory mediators and pattern-recognition receptors was assessed by RT-qPCR. Cytokine production and surface marker expression were evaluated by ELISA and flow cytometry, respectively. DC function was further assessed after interaction with CD4⁺ T lymphocytes, followed by analysis of T cell phenotype by flow cytometry and cytokine production by ELISA. LPS upregulated the transcription of intracellular receptors AIM2, NOD1, and NOD2 and increased COX-2, TNF-α, IL-1β, IL-6, CXCL-8, IL-12, and IL-18 mRNA levels compared with immature DCs (p < 0.001). Exposure to probiotics downregulated most genes encoding receptors and inflammatory mediators compared with LPS-stimulated DCs. In LPS-stimulated DCs, LA-5 reduced intra- and extracellular receptor gene expression, increased COX-2, TNF-α, IL-1β, IL-6, CXCL-8, and IL-10 transcription, and decreased IL-12 mRNA levels. LR-32 upregulated TLR2, COX-2, IL-6, CXCL-8, and IL-10, while reducing IL-12 expression, although these effects were less pronounced than those induced by LA-5. LA-5-exposed DCs induced a higher frequency of CD25highFOXP3highCD127low CD4⁺ T cells than LR-32. These findings indicate that LA-5 and LR-32 modulate human DC responses in a strain-dependent manner. Rather than acting as broadly anti-inflammatory stimuli, these probiotics reshaped LPS-induced activation by modulating pattern-recognition receptor pathways, cytokine responses, and a Treg-associated CD4⁺ T cell phenotype, suggesting a potential role in controlled mucosal immune regulation.
No takes yet. Share an insight, caveat, or question.
A 2026 study studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: